Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SRSF2-p95 hotspot mutation is highly associated with advanced forms of mastocytosis and mutations in epigenetic regulator genes
Katia Hanssens, Fabienne Brenet, Julie Agopian, et al.
Haematologica (2014) Vol. 99, Iss. 5, pp. 830-835
Open Access | Times Cited: 56

Showing 1-25 of 56 citing articles:

Connections between TET proteins and aberrant DNA modification in cancer
Yun Huang, Anjana Rao
Trends in Genetics (2014) Vol. 30, Iss. 10, pp. 464-474
Open Access | Times Cited: 237
Additional mutations in SRSF2, ASXL1 and/or RUNX1 identify a high-risk group of patients with KIT D816V+ advanced systemic mastocytosis
Mohamad Jawhar, Juliana Schwaab, Susanne Schnittger, et al.
Leukemia (2015) Vol. 30, Iss. 1, pp. 136-143
Closed Access | Times Cited: 201
Consensus Opinion on Allogeneic Hematopoietic Cell Transplantation in Advanced Systemic Mastocytosis
Celalettin Üstün, Jason Gotlib, Uday Popat, et al.
Biology of Blood and Marrow Transplantation (2016) Vol. 22, Iss. 8, pp. 1348-1356
Open Access | Times Cited: 90
Molecular Defects in Mastocytosis
Siham Bibi, Florent Langenfeld, Sylvie Jeanningros, et al.
Immunology and Allergy Clinics of North America (2014) Vol. 34, Iss. 2, pp. 239-262
Closed Access | Times Cited: 72
Mastocytosis: a mutated KIT receptor induced myeloproliferative disorder
Anindya Chatterjee, Joydeep Ghosh, Reuben Kapur
Oncotarget (2015) Vol. 6, Iss. 21, pp. 18250-18264
Open Access | Times Cited: 69
Advanced systemic mastocytosis: from molecular and genetic progress to clinical practice
Celalettin Üstün, Michel Arock, Hanneke C. Kluin‐Nelemans, et al.
Haematologica (2016) Vol. 101, Iss. 10, pp. 1133-1143
Open Access | Times Cited: 66
Deciphering the differentiation trajectory from hematopoietic stem cells to mast cells
Jennine Grootens, Johanna Ungerstedt, Gunnar Nilsson, et al.
Blood Advances (2018) Vol. 2, Iss. 17, pp. 2273-2281
Open Access | Times Cited: 61
Standards of Genetic Testing in the Diagnosis and Prognostication of Systemic Mastocytosis in 2022: Recommendations of the EU-US Cooperative Group
Gregor Hoermann, Karl Sotlar, Mohamad Jawhar, et al.
The Journal of Allergy and Clinical Immunology In Practice (2022) Vol. 10, Iss. 8, pp. 1953-1963
Open Access | Times Cited: 36
The international consensus classification of mastocytosis and related entities
Roos J. Leguit, Sa A. Wang, Tracy I. George, et al.
Virchows Archiv (2022) Vol. 482, Iss. 1, pp. 99-112
Closed Access | Times Cited: 31
The Data Registry of the European Competence Network on Mastocytosis (ECNM): Set Up, Projects, and Perspectives
Peter Valent, J. N. G. Oude Elberink, Aleksandra Górska, et al.
The Journal of Allergy and Clinical Immunology In Practice (2018) Vol. 7, Iss. 1, pp. 81-87
Open Access | Times Cited: 51
Clinical impact and proposed application of molecular markers, genetic variants, and cytogenetic analysis in mast cell neoplasms: Status 2022
Michel Arock, Gregor Hoermann, Karl Sotlar, et al.
Journal of Allergy and Clinical Immunology (2022) Vol. 149, Iss. 6, pp. 1855-1865
Open Access | Times Cited: 26
The genetic basis of mast cell activation disease - looking through a glass darkly
Gerhard J. Molderings
Critical Reviews in Oncology/Hematology (2014) Vol. 93, Iss. 2, pp. 75-89
Closed Access | Times Cited: 49
Impact of somatic and germline mutations on the outcome of systemic mastocytosis
Javier I. Muñoz‐González, María Jara‐Acevedo, Iván Álvarez‐Twöse, et al.
Blood Advances (2018) Vol. 2, Iss. 21, pp. 2814-2828
Open Access | Times Cited: 46
Splicing factor SRSF2-centric gene regulation
Kun Li, Ziqiang Wang
International Journal of Biological Sciences (2021) Vol. 17, Iss. 7, pp. 1708-1715
Open Access | Times Cited: 29
CD52 is a molecular target in advanced systemic mastocytosis
Gregor Hoermann, Katharina Blatt, Georg Greiner, et al.
The FASEB Journal (2014) Vol. 28, Iss. 8, pp. 3540-3551
Closed Access | Times Cited: 30
Neutrophilic leukocytosis in advanced stage polycythemia vera: hematopathologic features and prognostic implications
Leonardo Boiocchi, Umberto Gianelli, Alessandra Iurlo, et al.
Modern Pathology (2015) Vol. 28, Iss. 11, pp. 1448-1457
Open Access | Times Cited: 29
The Spectrum of Aggressive Mastocytosis: A Workshop Report and Literature Review
Roos J. Leguit, Konnie M. Hebeda, Marcus Kremer, et al.
Pathobiology (2019) Vol. 87, Iss. 1, pp. 2-19
Open Access | Times Cited: 27
KIT Mutations and Other Genetic Defects in Mastocytosis
Yannick Chantran, Peter Valent, Michel Arock
Immunology and Allergy Clinics of North America (2023) Vol. 43, Iss. 4, pp. 651-664
Open Access | Times Cited: 8
Detection of SRSF2-P95 Mutation by High-Resolution Melting Curve Analysis and Its Effect on Prognosis in Myelodysplastic Syndrome
Jiang Lin, Jing Yang, Xiang‐mei Wen, et al.
PLoS ONE (2014) Vol. 9, Iss. 12, pp. e115693-e115693
Open Access | Times Cited: 27
Transgenerational transmission of systemic mast cell activation disease—genetic and epigenetic features
Gerhard J. Molderings
Translational research (2016) Vol. 174, pp. 86-97
Closed Access | Times Cited: 25
Impact of centralized evaluation of bone marrow histology in systemic mastocytosis
Mohamad Jawhar, Juliana Schwaab, Hans‐Peter Horny, et al.
European Journal of Clinical Investigation (2016) Vol. 46, Iss. 5, pp. 392-397
Open Access | Times Cited: 25
Identification of a leukemia-initiating stem cell in human mast cell leukemia
Gregor Eisenwort, Irina Sadovnik, Juliana Schwaab, et al.
Leukemia (2019) Vol. 33, Iss. 11, pp. 2673-2684
Open Access | Times Cited: 24
Genetic Changes in Mastocytes and Their Significance in Mast Cell Tumor Prognosis and Treatment
Szymon Zmorzyński, Aleksandra Kimicka-Szajwaj, Angelika Szajwaj, et al.
Genes (2024) Vol. 15, Iss. 1, pp. 137-137
Open Access | Times Cited: 2
The detection of SRSF2 mutations in routinely processed bone marrow biopsies is useful in the diagnosis of chronic myelomonocytic leukemia
Birgit Federmann, Manuel Abele, David S Rosero, et al.
Human Pathology (2014) Vol. 45, Iss. 12, pp. 2471-2479
Closed Access | Times Cited: 24
Functions of TET Proteins in Hematopoietic Transformation
Jae‐A Han, Jungeun An, Myunggon Ko
Molecules and Cells (2015) Vol. 38, Iss. 11, pp. 925-935
Open Access | Times Cited: 24
Page 1 - Next Page

Scroll to top